CPAP Treatment and Postoperative Outcomes in Patients With Rheumatic Valvular Heart Disease

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

December 1, 2019

Study Completion Date

January 31, 2020

Conditions
Rheumatic Valvular Heart DiseaseObstructive Sleep Apnea
Interventions
DEVICE

continuous positive airway pressure

The CPAP treatment group received both baseline and CPAP treatment for 7 days preoperatively. The non-CPAP treatment group only received baseline treatment.

Trial Locations (1)

210029

The First Affiliated Hospital of Nanjing Medical University, Nanjing

Sponsors
All Listed Sponsors
lead

Nanjing Medical University

OTHER

NCT03398733 - CPAP Treatment and Postoperative Outcomes in Patients With Rheumatic Valvular Heart Disease | Biotech Hunter | Biotech Hunter